Related Experiment Videos
Esomeprazole-based therapy in Helicobacter pylori eradication: a meta-analysis
1Department of Gastroenterology, University Hospital of "la Princesa", Playa de Mojácar 29. Urb. Bonanza, 28669 Boadilla del Monte, Madrid, Spain. gisbert@meditex.es
Summary
Esomeprazole-based triple therapy effectively eradicates Helicobacter pylori infection. This systematic review found it comparable in efficacy to omeprazole-based treatments for H. pylori eradication.
Area of Science:
- Gastroenterology
- Pharmacology
- Infectious Diseases
Background:
- Helicobacter pylori infection is a significant global health concern.
- Proton pump inhibitors (PPIs) are crucial in H. pylori eradication therapies.
- Esomeprazole is a widely used PPI, but its efficacy in H. pylori eradication requires comprehensive evaluation.
Purpose of the Study:
- To systematically review the efficacy of esomeprazole-based therapies for H. pylori eradication.
- To conduct a meta-analysis comparing esomeprazole with other proton pump inhibitors in combination with antibiotics.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Inclusion criteria focused on studies comparing esomeprazole and other PPIs with antibiotics.
- Eradication success rates were calculated as weighted means and odds ratios.
Main Results:
- Dual esomeprazole regimens achieved cure rates of 51-54%.
- Triple esomeprazole regimens demonstrated high efficacy with cure rates of 82-86%.
- Meta-analysis showed esomeprazole-based therapy (85%) had comparable efficacy to omeprazole-based therapy (82%) for H. pylori eradication (OR=1.19).
Conclusions:
- Esomeprazole-based triple therapy is a highly effective strategy for H. pylori eradication.
- Esomeprazole demonstrates comparable efficacy to omeprazole when used in H. pylori eradication regimens.
- These findings support the use of esomeprazole in standard H. pylori treatment protocols.